Elliott RL et al. |
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572890
|
Griesgraber G et al. |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. |
1998 |
J. Med. Chem. |
pmid:9572891
|
Al-Sibai MB et al. |
Ocular penetration of oral clarithromycin in humans. |
1998 |
J Ocul Pharmacol Ther |
pmid:9867340
|
Wallace RJ and Brown BA |
Catheter sepsis due to Mycobacterium chelonae. |
1998 |
J. Clin. Microbiol. |
pmid:9867491
|
Pipkin GA et al. |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768524
|
Louw JA et al. |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768531
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Jarboe E et al. |
Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9572027
|
Treiber G et al. |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. |
1998 |
Helicobacter |
pmid:9546119
|
Suzuki J et al. |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan. |
1998 |
Helicobacter |
pmid:9546120
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Sasa K et al. |
[Antineoplastic therapeutic effect of clarithromycin in rats]. |
1998 |
Jpn J Antibiot |
pmid:9597492
|
Miyamoto N et al. |
[Test to set dosages for long-term administration of clarithromycin to treat chronic paranasal sinusitis]. |
1998 |
Jpn J Antibiot |
pmid:9597498
|
Fujita K et al. |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics]. |
1998 |
Jpn J Antibiot |
pmid:9597505
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers. |
1998 |
Am. J. Gastroenterol. |
pmid:9517644
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Roussel G and Igual J |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries. |
1998 |
Int. J. Tuberc. Lung Dis. |
pmid:9626603
|
Nordt SP et al. |
Clarithromycin induced digoxin toxicity. |
1998 |
J Accid Emerg Med |
pmid:9639187
|
Gray VS |
Syncopal episodes associated with cisapride and concurrent drugs. |
1998 |
Ann Pharmacother |
pmid:9640482
|
Grove DI et al. |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. |
1998 |
Pathology |
pmid:9643503
|
Guerriero SE et al. |
Two cases of clarithromycin-induced digoxin toxicity. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324195
|
Anzueto A et al. |
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group. |
1997 Sep-Oct |
Clin Ther |
pmid:9385486
|
Svoboda P et al. |
Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. |
1997 May-Jun |
Hepatogastroenterology |
pmid:9222709
|
Best LM et al. |
Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218854
|
O'Brien B et al. |
Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer. |
1997 May-Jun |
Can. J. Gastroenterol. |
pmid:9218858
|
al-Humayyd MS |
Pharmacokinetic interactions between erythromycin, clarithromycin, roxithromycin and phenytoin in the rat. |
1997 Mar-Apr |
Chemotherapy |
pmid:9084915
|
Grunden JW and Fisher KA |
Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220046
|
Tartaglione T |
Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. |
1997 Jul-Aug |
Clin Ther |
pmid:9377608
|
Mikasa K et al. |
Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. |
1997 Jul-Aug |
Chemotherapy |
pmid:9209786
|
Nawarskas JJ et al. |
Digoxin toxicity secondary to clarithromycin therapy. |
1997 Jul-Aug |
Ann Pharmacother |
pmid:9220047
|
Dautzenberg B et al. |
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections. |
1997 Jan-Feb |
Infection |
pmid:9039532
|
Kearsley NL et al. |
Comparison of clarithromycin suspension and amoxycillin syrup for the treatment of children with pharyngitis and/or tonsillitis. |
1997 Apr-May |
Br J Clin Pract |
pmid:9293051
|
Irie Y et al. |
Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301989
|
Stone GG et al. |
PCR-RFLP typing of ureC from Helicobacter pylori isolated from gastric biopsies during a European multi-country clinical trial. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301991
|
López-Brea M et al. |
Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain. |
1997 |
J. Antimicrob. Chemother. |
pmid:9301996
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Verhaegen J et al. |
Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae. |
1997 |
Acta Clin Belg |
pmid:9204588
|
Kim MJ et al. |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment. |
1997 |
Gastroenterology |
pmid:9207259
|
Gotoh A et al. |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. |
1997 |
Microbiol. Immunol. |
pmid:9087962
|
Driscoll MS and Tyring SK |
Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. |
1997 |
J. Am. Acad. Dermatol. |
pmid:9091495
|
Gui GP et al. |
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096189
|
Hoogkamp-Korstanje JA et al. |
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. |
1997 |
J. Antimicrob. Chemother. |
pmid:9096192
|
Fujii K et al. |
Multiple primary Mycobacterium avium infection of the skin. |
1997 |
Int. J. Dermatol. |
pmid:9071619
|
Yanagihara K et al. |
Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. |
1997 |
Am. J. Respir. Crit. Care Med. |
pmid:9001333
|
Gan VN et al. |
Penetration of clarithromycin into middle ear fluid of children with acute otitis media. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9002099
|
Denys A |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. |
1997 |
Otolaryngol Pol |
pmid:9757681
|
Pendland SL et al. |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones. |
1997 |
J. Clin. Microbiol. |
pmid:9350781
|
Kubas G and Gospodarek T |
[The use of clarithromycin and amoxycillin in pediatric acute otitis media]. |
1997 |
Otolaryngol Pol |
pmid:9757683
|
Ridgway GL et al. |
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. |
1997 |
J. Antimicrob. Chemother. |
pmid:9484871
|
Martin SJ et al. |
In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9401809
|
Sander P et al. |
The role of ribosomal RNAs in macrolide resistance. |
1997 |
Mol. Microbiol. |
pmid:9402018
|
Brancato R et al. |
Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. |
1997 |
Arch. Ophthalmol. |
pmid:9338681
|
Jingu K et al. |
[A case of fluminant Mycoplasma pneumonia and bronchiolitis managed by artificial respiration]. |
1997 |
Nippon Naika Gakkai Zasshi |
pmid:9340346
|
Szántó D et al. |
[Could Helicobacter pylori cause reactive arthro-osteitis?]. |
1997 |
Orv Hetil |
pmid:9340585
|
Yamamoto M et al. |
[The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection]. |
1997 |
Kekkaku |
pmid:9038009
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Greco S et al. |
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. |
1997 |
Ann Pharmacother |
pmid:9416400
|
Sugihara J et al. |
[Efficacy of clarithromycin on chronic paranasal sinusitis--a comparison between children and adult]. |
1997 |
Jpn J Antibiot |
pmid:9597431
|
Hamada K et al. |
[Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. |
1997 |
Jpn J Antibiot |
pmid:9597434
|
Dautzenberg B |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. |
1997 |
Drugs |
pmid:9358194
|
Cohn DL |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. |
1997 |
Drugs |
pmid:9358195
|
Tzivras M et al. |
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. |
1997 |
Eur J Gastroenterol Hepatol |
pmid:9471024
|
Kawasaki M et al. |
Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. |
1997 |
Am. J. Gastroenterol. |
pmid:9382064
|
Adamek RJ et al. |
Pantoprazole versus omeprazole in one-week low-dose triple therapy for curve of H. pylori infection. |
1997 |
Am. J. Gastroenterol. |
pmid:9382084
|
McLaren A et al. |
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics. |
1997 |
Helicobacter |
pmid:9432317
|
Bardhan KD et al. |
Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole. |
1997 |
Helicobacter |
pmid:9432318
|
Takimoto T et al. |
The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients. |
1997 |
Helicobacter |
pmid:9432334
|
Moayyedi P |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin? |
1997 |
Ital J Gastroenterol Hepatol |
pmid:9513823
|
Pieramico O et al. |
Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial. |
1997 |
Helicobacter |
pmid:9432335
|
Konishi T and Nakao M |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. |
1997 |
Microbiol. Immunol. |
pmid:9087959
|
GarcÃa-de-Lomas J et al. |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063666
|
Weiss I et al. |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063669
|
Bordet AL et al. |
[Mycobacterium chelonae cutaneous infection: efficacy of prolonged treatment by clarithromycin]. |
1997 |
Ann Dermatol Venereol |
pmid:9686059
|
Thornsberry C et al. |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9458982
|
Briant C et al. |
Pericarditis as a manifestation of Lyme disease. |
1997 |
J Emerg Nurs |
pmid:9460386
|
Feldman C et al. |
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. |
1997 |
Inflammation |
pmid:9429912
|
Lévy M et al. |
Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. |
1997 |
Gastrointest. Endosc. |
pmid:9351036
|
Laine L et al. |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354200
|
Rinaldi V et al. |
The management of failed dual or triple therapy for Helicobacter pylori eradication. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354202
|
Breuer T et al. |
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354204
|
Wurzer H et al. |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354205
|
Harris A |
H. pylori eradication by LAC. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9354216
|
Barry AL et al. |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9405952
|
Mitsuyama T et al. |
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide. |
1997 |
Int. Arch. Allergy Immunol. |
pmid:9338603
|
Laine L et al. |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. |
1997 |
Am. J. Gastroenterol. |
pmid:9399755
|
Midolo PD et al. |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. |
1997 |
Pathology |
pmid:9423225
|
Srinivasan R and Minocha A |
Cure of Helicobacter pylori: a hidden curse? |
1997 |
Am. J. Gastroenterol. |
pmid:9399784
|
|
Different clarithromycin doses affect mortality. |
1997 |
AIDS Patient Care STDS |
pmid:11361754
|
Sekkarie MA |
Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin. |
1997 |
Am. J. Kidney Dis. |
pmid:9292575
|
Akaki T et al. |
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice]. |
1997 |
Kekkaku |
pmid:9293712
|
Recker MW and Kier KL |
Potential interaction between clarithromycin and warfarin. |
1997 |
Ann Pharmacother |
pmid:9296238
|
Laberge P and Martineau P |
Clarithromycin-induced digoxin intoxication. |
1997 |
Ann Pharmacother |
pmid:9296239
|
Bardhan KD et al. |
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. |
1997 |
Gut |
pmid:9301496
|